REDMOND, Wash., July 20, 2016 (GLOBE NEWSWIRE) -- S-Ray Incorporated announced today that it has launched on its website a "Testing the Waters" campaign at: http://s-rayinc.com/invest.
The campaign is intended to gauge potential investor interest in a going public transaction – an IPO via Regulation A Plus Tier II. S-Ray is measuring public support for a possible offering by targeting the general investment and dental industry communities as well as socially responsible investors as it seeks to raise up to $50 million of additional capital to support growth strategies and operational goals. S-Ray’s intention is to file a Regulation A Plus with the Securities and Exchange Commission (SEC) once the "Testing the Waters" campaign reaches the threshold of $1 million.
In the past, only qualified investors, venture capitalists, and private equity firms had the opportunity to invest via special securities in private-to-public transactions. This changed in June 2015 with the passage of the JOBS Act in April 2012 and the SEC's release of the regulations governing the new rules.
S-Ray intends to participate in these new rules under Regulation A Plus Tier II. But before any investment into a Regulation A Plus offering can occur, The Company must first qualify its potential offering with Federal regulators and launch its "Testing the Waters" campaign to gauge market interest. The campaign will target potential investors through email, social media campaigns and by inviting investors to participate.
“We have been anticipating the next major steps of growth for our company,” said Steve Baird, S-Ray Incorporated’s CEO. “So we welcome the possibilities afforded by an IPO via Regulation A Plus Tier II.”
No money or other consideration is being solicited in S-Ray’s “Testing the Waters” campaign, and, if sent, in response, it will not be accepted. Offers to buy securities cannot be accepted, and no sales of securities will be made or commitment to purchase accepted until qualification of the offering statement by the SEC and the approval of any other required government or regulatory agency. An indication of interest made by a prospective investor is non-binding and involves no obligation or commitment of any kind. No offer of securities will be made without a qualified offering circular.
Any eventual Regulation A Plus offering will be presented to investors in the order they participate in the "Testing the Waters" campaign. Potential investors can indicate their interest in the campaign at S-Ray’s dedicated webpage: http://s-rayinc.com/invest/testing-the-waters-campaign/testing-the-waters-campaign-potential-investors/.
About S-Ray Incorporated
S-Ray Incorporated is a biotech dental company that is developing a low cost 3D imaging system for use by dentists. The products will arrive on the market at a crucial juncture — providing low cost 3D imaging for the dental industry. S-Ray was founded in 2008 and is located in Redmond, Washington, where it is part of the Seattle-area’s “ultrasound cluster,” a collection of businesses, research facilities, organizations and more, all of whom are centered around the development of ultrasound technology. S-Ray Incorporated has been issued its first patent, which provides coverage for the unique way of using ultrasound for dental applications. An additional 31 provisional patents have been secured for other aspects of the system and additional software. Learn more about the company and its breakthrough use of ultrasound for dental imaging at www.s-rayinc.com.
Forward-looking & Safe Harbor Statement
Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Exchange Act of 1934, and those statements are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this release, including, without limitation, statements regarding potential plans and objectives of the Company, are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. S-Ray cautions that these forward-looking statements are further qualified by other factors. S-Ray undertakes no obligation to publicly update or revise any statements in this release, whether as a result of new information, future events or otherwise.
Contact: David Row 503.341.1285 firstname.lastname@example.org